+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "T Cell Immunotherapy"

T-Cell Immunotherapy Market by Therapy Type (CAR-T Therapy, TCR Therapy, TIL Therapy), Cell Source (Allogeneic Cells, Autologous Cells), Target Antigens, Manufacturing Method, Patient Type, Indication, End-User - Global Forecast 2025-2030 - Product Thumbnail Image

T-Cell Immunotherapy Market by Therapy Type (CAR-T Therapy, TCR Therapy, TIL Therapy), Cell Source (Allogeneic Cells, Autologous Cells), Target Antigens, Manufacturing Method, Patient Type, Indication, End-User - Global Forecast 2025-2030

  • Report
  • March 2025
  • 180 Pages
  • Global
From
TCR Therapy Market Industry Trends and Global Forecasts to 2035, by Target Indication, Target Antigen, Key Players and Key Geographies - Product Thumbnail Image

TCR Therapy Market Industry Trends and Global Forecasts to 2035, by Target Indication, Target Antigen, Key Players and Key Geographies

  • Report
  • January 2025
  • 363 Pages
  • Global
From
CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035 - Product Thumbnail Image

CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035

  • Report
  • December 2024
  • 598 Pages
  • Global
From
TIL Therapies Market Industry Trends and Global Forecasts to 2035, by Target Indication, Key Players and Key Geographical Regions - Product Thumbnail Image

TIL Therapies Market Industry Trends and Global Forecasts to 2035, by Target Indication, Key Players and Key Geographical Regions

  • Report
  • February 2025
  • 315 Pages
  • Global
From
T-Cell Therapy Market by Type of Therapy, Target Indication, Target Antigen, Company Size, Geographical Regions, Leading Players and Sales Forecast of Therapies, Industry Trends and Global Forecasts to 2035 - Product Thumbnail Image

T-Cell Therapy Market by Type of Therapy, Target Indication, Target Antigen, Company Size, Geographical Regions, Leading Players and Sales Forecast of Therapies, Industry Trends and Global Forecasts to 2035

  • Report
  • March 2025
  • 1048 Pages
  • Global
From
Cellular Immunotherapy Market by Type (CAR T-Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy), Technology Type (Cytokines & Immunomodulators, Monoclonal Antibodies), Indication, Institution Category - Global Forecast 2025-2030 - Product Thumbnail Image

Cellular Immunotherapy Market by Type (CAR T-Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy), Technology Type (Cytokines & Immunomodulators, Monoclonal Antibodies), Indication, Institution Category - Global Forecast 2025-2030

  • Report
  • March 2025
  • 187 Pages
  • Global
From
CAR T-cell Therapy Market by Indication, Type, End-Use - Global Forecast 2025-2030 - Product Thumbnail Image

CAR T-cell Therapy Market by Indication, Type, End-Use - Global Forecast 2025-2030

  • Report
  • October 2024
  • 181 Pages
  • Global
From
T-Cell Therapy Market by Modality, Therapy Type, Indication - Global Forecast 2025-2030 - Product Thumbnail Image

T-Cell Therapy Market by Modality, Therapy Type, Indication - Global Forecast 2025-2030

  • Report
  • October 2024
  • 182 Pages
  • Global
From
Cancer Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Cancer Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 100 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2024 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 280 Pages
  • Global
From
Oncology Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Oncology Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • July 2024
  • 100 Pages
  • Global
From
CAR-T Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

CAR-T Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • June 2024
  • 182 Pages
  • Global
From
CD47 Targeting Therapeutics Market by Target Disease Indication, Type of Molecule Key Players and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2035 - Product Thumbnail Image

CD47 Targeting Therapeutics Market by Target Disease Indication, Type of Molecule Key Players and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2035

  • Report
  • September 2021
  • 178 Pages
  • Global
From
Global CAR T Cell Therapy Market Opportunity & Clinical Pipeline Insight 2028 - Product Thumbnail Image

Global CAR T Cell Therapy Market Opportunity & Clinical Pipeline Insight 2028

  • Drug Pipelines
  • May 2022
  • 400 Pages
  • Global
From
Current Research & Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy - Product Thumbnail Image

Current Research & Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy

  • Report
  • December 2021
  • 353 Pages
  • Global
From
Targeted Immunotherapy in Oncology - Product Thumbnail Image

Targeted Immunotherapy in Oncology

  • Report
  • November 2021
  • 106 Pages
  • Global
From
Epstein-Barr Virus-associated Post-Transplant Lymphoproliferative Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Epstein-Barr Virus-associated Post-Transplant Lymphoproliferative Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Post-transplant Lymphoproliferative Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Post-transplant Lymphoproliferative Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
CAR T - Cell Therapy - Competitive landscape, 2023 - Product Thumbnail Image

CAR T - Cell Therapy - Competitive landscape, 2023

  • Report
  • April 2023
  • 500 Pages
  • Global
From
CAR-T Cell Therapy Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

CAR-T Cell Therapy Market Analysis & Forecast to 2024-2034

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Loading Indicator

T Cell Immunotherapy is a type of immune disorder drug that works by harnessing the power of a patient's own immune system to fight disease. It involves the extraction of T cells from a patient's blood, which are then genetically modified to recognize and attack cancer cells. This modified T cell is then reintroduced into the patient's body, where it can recognize and destroy cancer cells. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. T Cell Immunotherapy has been shown to be effective in treating certain types of cancer, and is being studied for its potential to treat other types of cancer and immune disorders. It is also being studied for its potential to treat autoimmune diseases, such as rheumatoid arthritis and type 1 diabetes. Some companies in the T Cell Immunotherapy market include Novartis, Kite Pharma, Juno Therapeutics, and Celgene. Show Less Read more